Significant Ownership of JOHN R. MURPHY

Location
Springfield, MO
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by JOHN R. MURPHY.

Notify me when JOHN R. MURPHY files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of JOHN R. MURPHY

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CVKD Cadrenal Therapeutics, Inc. Common Stock, $0.001 par value per share 2.96% $899K 53.2K John Raymond Murphy 31 Dec 2024

Schedules 13D/G Reported by JOHN R. MURPHY:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.